Refer-a-Friend
Join UsRefine Results
Advocacy
-
AIPLA Comments on United States Patent and Trademark Office Draft Strategic Plan for FY 2018-2022
October 5, 2018 The Honorable Andrei Iancu Under Secretary of Commerce for Intellectual Property and Director of U.S. Patent and Trademark Office U.S. Patent and Trademark Office 600 Dulany Street Alexandria, VA 22314 Via email: Strategicplanning1@uspto.gov RE: Comments on United States Patent and Trademark Office Draft Strategic Plan for FY 2018-2022 Dear Under
-
Letter to Senate Committee on Rules and Administration in Support for the Register of Copyrights Selection and Accountability Act of 2017
September 24, 2018 The Honorable Roy Blunt The Honorable Amy Klobuchar Chairman Ranking Member Committee on Rules and Administration Committee on Rules and Administration United States Senate United States Senate 305 Russell Senate Office Building
-
Letter to the House Judiciary Committee in Support of the CASE Act of 2017
September 24, 2018 The Honorable Bob Goodlatte The Honorable Jerrold Nadler Chairman Ranking Member Committee on the Judiciary Committee on the Judiciary United States House of Representatives United States House of Representatives 2138 Rayburn House Office Building 2109 Rayburn House Office Building Washington, DC 20515 Washington, DC 20515 Re: Support for H.R. 39
-
AIPLA Comments Submitted Pursuant to "Notice of Proposed Rulemaking on Copyright Office Fees," September 21, 2018
Honorable Karyn A. Temple Acting Register of Copyrights U.S. Copyright Office 101 Independence Avenue, SE Washington, DC 20559-6000 Via: https://www.copyright.gov/policy/feestudy2018 Re: Comments Submitted Pursuant to Notice of Proposed Rulemaking on Copyright Office Fees, 83 Fed. Reg. 101 (May 24, 2018) Dear Acting Register Temple: The American Intellectual Property Law As
-
H.R. 3301, CLASSICS Act
-
H.R. 3945, CASE Act of 2017
-
AIPLA Comments on FDA Public Hearing on Facilitating Competition and Innovation in the Biological Products Workplace
Microsoft Word - AIPLA Comments on FDA FRN Notice and Public Hearing 2018Sep19-word September 19, 2018 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: AIPLA Comments on Docket No. FDA-2018-N-2689, Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request
-
Letter to House Judiciary Committee in Support of Extending the USPTO Fee-Setting Authority
Since 1897 September 12, 2018 The Honorable Bob Goodlatte The Honorable Jerrold Nadler Chairman Ranking Member Committee on the Judiciary Committee on the Judiciary United States House of Representatives United States House of Representatives 2138 Rayburn House Office Building 2142 Rayburn House Office Building Washington, DC 20515 Washington, DC 20515
-
AIPLA Comments to the Patent Public Advisory Committee Public Hearing in the Proposed Patent Fee Schedule
September 11, 2018 Brendan Hourigan Director, Office of Planning and Budget Office of the Chief Financial Officer United States Patent and Trademark Office 600 Dulany Street Alexandria, VA 22314 Via email: fee.setting@uspto.gov RE: Comments to the Patent Public Advisory Committee Public Hearing on the Proposed Patent Fee Schedule [Docket No. PTO-P-2018-0046] Dear Mr. H
-
AIPLA/IPO/INTA Letter Urging the Senate Judiciary Committee to Take Up Legislation to Amend the Lanham Act
September 4, 2018 The Honorable Charles Grassley The Honorable Dianne Feinstein Chairman Ranking Member Senate Committee on the Judiciary Senate Committee on the Judiciary U.S. Senate U.S. Senate Washington, D